Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 218,375 | 191,203 | 195,999 | 170,992 | 150,042 |
| Cost of Goods | 13,564 | 14,725 | 12,329 | 11,912 | 13,448 |
| Gross Profit | 204,811 | 176,478 | 183,670 | 159,080 | 136,594 |
| Operating Expenses | 255,021 | 240,560 | 210,956 | 206,101 | 173,756 |
| Operating Income | -49,646 | -63,357 | -26,957 | -46,109 | -36,714 |
| Interest Expense | 1,540 | 1,185 | 1,172 | 1,120 | 1,834 |
| Other Income | 0 | 0 | 0 | 0 | -10,385 |
| Pre-tax Income | -51,186 | -64,542 | -28,129 | -47,229 | -48,933 |
| Income Tax | 128 | N/A | 430 | N/A | -960 |
| Net Income Continuous | -51,314 | -64,542 | -28,559 | -47,229 | -47,973 |
| Net Income | $-51,314 | $-64,542 | $-28,559 | $-47,229 | $-47,973 |
| EPS Basic Total Ops | -0.99 | -1.26 | -0.55 | -0.94 | -0.97 |
| EPS Basic Continuous Ops | -0.99 | -1.26 | -0.55 | -0.94 | -0.97 |
| EPS Diluted Total Ops | -0.99 | -1.26 | -0.55 | -0.94 | -0.97 |
| EPS Diluted Continuous Ops | -0.99 | -1.26 | -0.55 | -0.94 | -0.97 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.26 | -0.71 | -0.94 | -0.92 |
| EBITDA(a) | $-46,595 | $-60,831 | $-24,522 | $-43,540 | $-34,151 |